Dr. Christopher Scott Carlin, MD

Dr. Carlin practices at Southern California Dermatology in San Clemente, California.

Dr. Carlin's NPI, 1336186493, was assigned on May 31, 2006. Dr. Carlin graduated from Spencer Fox Eccles School of Medicine in 2001. Dr. Carlin holds California license A80306.

Dr. Carlin's primary practice is Southern California Dermatology, at 1300 Avenida Vista Hermosa, San Clemente, CA 92673 in Orange County. The practice phone is (949) 644-0101.

Dr. Carlin's primary practice is Southern California Dermatology in San Clemente, California. The medical group on file is West Dermatology. Dmand AI also links Dr. Carlin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carlin practices. Vendor and product names are available with a free account.

Procedural dermatology is Dr. Carlin's primary specialty in the NPI Registry, under taxonomy code 207NS0135X. Dr. Carlin is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Carlin's licenses on file in 4 states: California, New York, Wisconsin and Utah.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Carlin treats.

CMS data shows 20,328 Medicare services from Dr. Carlin across 28 procedure codes in 2024, for 804 Medicare patients. Medicare paid $721,547 for them. Every service was in an office.

CMS counts 804 Medicare patients who saw Dr. Carlin in 2024. The largest group is 65 to 74, with 369 patients. 75% of them have high cholesterol, and 61% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Carlin's median patient age at 62, with 50% women.

In 2024, Dr. Carlin wrote 1,320 Medicare Part D claims for 453 patients. 97% of them were for generic drugs. CMS names the drug for 1,229 of them, across 17 drugs with 11 or more claims each, at $29,142 in total drug cost. In 2023, CMS named 1,132 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Carlin for performance year 2024, reported as part of a group. Dr. Carlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 6,397 procedures of removal of skin lesions by Dr. Carlin, more than 99% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Carlin in 2002. The most frequent topics are Psoriasis and Ultraviolet Therapy. Dr. Carlin has published most often in Arch Dermatol. Dr. Carlin's most frequent co-authors are Melissa P. Chiang, MD, Rand Lee Colbert, MD and Lawrence F. Eichenfield, MD.

CMS Open Payments shows 576 general payments to Dr. Carlin from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Abbvie Inc. paid the most, $1,797.

Dmand AI lists 2 awards for Dr. Carlin, most recently AAD Fellow in 2013.

Dr. Carlin graduated from Spencer Fox Eccles School of Medicine in 2001. Dr. Carlin is a member of AAD.

Dr. Carlin is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.